Eltrombopag post autologous hematopoietic stem cell transplant - an emerging indication in younger pediatric patients
AJBR Copyright © 2021..
BACKGROUND: Engraftment of neutrophils and platelets after hematopoietic stem cell transplant (HSCT) is imperative for optimal outcomes. Eltrombopag has been used in adults after HSCT to boost platelet production. Its use in pediatric post HSCT patients has been limited.
METHODS: The clinical and laboratory details of a post autologous HSCT patient were fetched by a retrospective review of the records.
RESULTS: A 5-year old male child had primary thrombocytopenia post autologous HSCT for refractory Hodgkin lymphoma. Although the stem cell dose infused was adequate, the child had a delay in the engraftment of platelets. After ruling out the causes of post HSCT thrombocytopenia, eltrombopag was started for the child. With the use of eltrombopag, normal thrombopoiesis was restored in the child.
CONCLUSION: Eltrombopag was effective and safe in overcoming post-HSCT primary thrombocytopenia in our patient.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
American journal of blood research - 11(2021), 2 vom: 21., Seite 168-171 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gupta, Aditya Kumar [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 05.06.2021 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM326280324 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM326280324 | ||
| 003 | DE-627 | ||
| 005 | 20231226203117.0 | ||
| 007 | tu | ||
| 008 | 231225s2021 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n1087.xml |
| 035 | |a (DE-627)NLM326280324 | ||
| 035 | |a (NLM)34079631 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gupta, Aditya Kumar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Eltrombopag post autologous hematopoietic stem cell transplant - an emerging indication in younger pediatric patients |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Revised 05.06.2021 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a AJBR Copyright © 2021. | ||
| 520 | |a BACKGROUND: Engraftment of neutrophils and platelets after hematopoietic stem cell transplant (HSCT) is imperative for optimal outcomes. Eltrombopag has been used in adults after HSCT to boost platelet production. Its use in pediatric post HSCT patients has been limited | ||
| 520 | |a METHODS: The clinical and laboratory details of a post autologous HSCT patient were fetched by a retrospective review of the records | ||
| 520 | |a RESULTS: A 5-year old male child had primary thrombocytopenia post autologous HSCT for refractory Hodgkin lymphoma. Although the stem cell dose infused was adequate, the child had a delay in the engraftment of platelets. After ruling out the causes of post HSCT thrombocytopenia, eltrombopag was started for the child. With the use of eltrombopag, normal thrombopoiesis was restored in the child | ||
| 520 | |a CONCLUSION: Eltrombopag was effective and safe in overcoming post-HSCT primary thrombocytopenia in our patient | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Eltrombopag | |
| 650 | 4 | |a autologous HSCT | |
| 650 | 4 | |a pediatric | |
| 700 | 1 | |a Srinivasan, Prasanth |e verfasserin |4 aut | |
| 700 | 1 | |a Das, Gargi |e verfasserin |4 aut | |
| 700 | 1 | |a Meena, Jagdish Prasad |e verfasserin |4 aut | |
| 700 | 1 | |a Tanwar, Pranay |e verfasserin |4 aut | |
| 700 | 1 | |a Seth, Rachna |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of blood research |d 2011 |g 11(2021), 2 vom: 21., Seite 168-171 |w (DE-627)NLM216338336 |x 2160-1992 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2021 |g number:2 |g day:21 |g pages:168-171 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2021 |e 2 |b 21 |h 168-171 | ||